Latham & Watkins Represents Hinge Health in US$437.31 Million IPO

Hinge Health has announced the pricing of its initial public offering of an aggregate 13,666,000 shares of its Class A common stock, 8,522,528 of which are being sold by Hinge Health and 5,143,472 of which are being sold by certain selling stockholders, at a public offering price of US$32 per share. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 2,049,900 shares of Class A common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the New York Stock Exchange on May 22, 2025, under the ticker symbol “HNGE.” The offering is expected to close on May 23, 2025, subject to customary closing conditions.

Latham & Watkins LLP represents Hinge Health in the offering with a capital markets team led by Bay Area partners Tad Freese and Erica Kassman, with associates Raul Gonzalez-Casarrubias, Isabelle Sawhney, Abid Ahmed, Shelby Harrison, and Taleah Tyrell. Advice was also provided on executive compensation, employment, and benefits matters by Bay Area partner Ashley Wagner, with associate Will Fowler; on regulatory matters by Bay Area partner Betty Pang and Washington, D.C. counsel Chad Jennings; on tax matters by Bay Area partner Grace Lee, with associate Rasha Suleiman; on intellectual property matters by Bay Area partner Anthony Klein, with associate Julian Savelski; and on data privacy matters by Bay Area partner Heather Deixler, with associate Gaby Forte.